** Shares of Medical equipment maker Thermo Fisher
Scientific Inc TMO.N down 0.6% at $485.75
** TMO to acquire Sweden-based provider of protein analysis
products Olink Holding AB OLK.O in a deal valued at $3.1 bln
** Deal also includes net cash of about $143 mln
** TMO plans to fund transaction using its cash on hand and
debt financing; expects deal to be closed by mid 2024
** In first full year, deal is expected to be dilutive to
TMO's adj. EPS by $0.17
** TMO shares down 11.4% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))